Larotrectinib sulfate is the sulfate salt form of larotrectinib, an orally available inhibitor of tropomyosin receptor kinase (Trk). It is used as an active pharmaceutical ingredient in the manufacturing of pharmaceutical products for cancer research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1223405-08-0
Larotrectinib
pharmaceutical raw material
Islet amyloid polypeptide
pharmaceutical raw material
2-[(5-chloro-2-{[3-methyl-1-(propan-2-yl)-1H-pyrazol-5-yl]amino}pyridin-4-yl)amino]-N-methoxybenzamide
pharmaceutical raw material
Protriptyline hydrochloride
pharmaceutical raw material
Faropenem sodium
pharmaceutical raw material
(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acid
PXHANKVTFWSDSG-QLOBERJESA-N
C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F.OS(=O)(=O)O